Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Two young siblings experienced hair loss without hormone issues or other skin problems.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

High levels of prolactin in the blood can be linked to widespread hair loss.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Check and treat low iron and vitamin D levels in people with hair loss.

Malnutrition can cause unusual eyelash growth and hair loss.

The document concluded that cyproterone acetate and minoxidil are effective for female hair loss, and a supportive doctor-patient relationship is important.

TrichoScan effectively diagnoses different types of hair loss and is linked to low iron stores in patients.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Stem cell treatment improved hair density in female hair loss patient.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Higher iron levels in the blood are not linked to increased hair loss in women.

Dermoscopy effectively distinguishes between acute total hair loss and other types of female hair loss.